Benzinga’s Top Ratings Upgrades, Downgrades For December 21, 2022
Upgrades For PagSeguro Digital Ltd (NYSE:PAGS), New Street Research upgraded the previous rating of Neutral to Buy. In…
Surgalign Expands Adoption Of Its HOLO Portal Surgical Guidance System In Virginia
Surgalign Holdings, Inc., (NASDAQ:SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced additional commercialization of its HOLO
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday’s Session
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.
Crude Oil Down Over 1%; Lincoln National Shares Plunge
U.S. stocks pared some losses midway through trading, with the Nasdaq Composite dropping around 80 points on Thursday.
Surgalign Announces Third Clinical Site In The Commercialization And Performs First Case Of Its HOLO Portal Surgical Guidance System
DEERFIELD, Ill., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ:SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today
Recap Of Wednesday’s Biotech Catalysts – End Of the Day Summary
The European Commission (EC) has granted conditional marketing authorization (CMA) to BioMarin Pharmaceutical’s (NASDAQ:BMRN) lead asset ROCTAVIAN (valoctocogene…
Surgalign Scores FDA Approval For New Flagship Posterior Fixation Platform
Surgalign Holdings Inc (NASDAQ:SRGA) announced FDA 510(k) clearance of the Cortera Spinal Fixation System, a key piece to the foundational portfolio…
Surgalign Gets FDA 510(k) Clearance For Spinal Fixation System
Surgalign Holdings (NASDAQ: SRGA) announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Cortera Spinal Fixation System.
Surgalign Holdings Q2 EPS $(1.91) Beats $(2.25) Estimate, Sales $20.62M Miss $21.13M Estimate
Surgalign Holdings (NASDAQ:SRGA) reported quarterly losses of $(1.91) per share which beat the analyst consensus estimate of $(2.25) by 15.11 percent. This is a 46.94 percent increase over losses of $(3.60) per share